309 related articles for article (PubMed ID: 18816788)
1. Differential alteration of hippocampal excitatory synaptic transmission by cannabinoid ligands.
Bajo M; Roberto M; Schweitzer P
J Neurosci Res; 2009 Feb; 87(3):766-75. PubMed ID: 18816788
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid receptor agonists potentiate action potential-independent release of GABA in the dentate gyrus through a CB1 receptor-independent mechanism.
Hofmann ME; Bhatia C; Frazier CJ
J Physiol; 2011 Aug; 589(Pt 15):3801-21. PubMed ID: 21646412
[TBL] [Abstract][Full Text] [Related]
3. Endocannabinoids mediate presynaptic inhibition of glutamatergic transmission in rat ventral tegmental area dopamine neurons through activation of CB1 receptors.
Melis M; Pistis M; Perra S; Muntoni AL; Pillolla G; Gessa GL
J Neurosci; 2004 Jan; 24(1):53-62. PubMed ID: 14715937
[TBL] [Abstract][Full Text] [Related]
4. Endocannabinoid- and mGluR5-dependent short-term synaptic depression in an isolated neuron/bouton preparation from the hippocampal CA1 region.
Sheinin A; Talani G; Davis MI; Lovinger DM
J Neurophysiol; 2008 Aug; 100(2):1041-52. PubMed ID: 18497350
[TBL] [Abstract][Full Text] [Related]
5. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices.
Ameri A; Wilhelm A; Simmet T
Br J Pharmacol; 1999 Apr; 126(8):1831-9. PubMed ID: 10372827
[TBL] [Abstract][Full Text] [Related]
6. Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices.
Ameri A; Simmet T
Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):265-72. PubMed ID: 10731038
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ.
Du H; Chen X; Zhang J; Chen C
Br J Pharmacol; 2011 Aug; 163(7):1533-49. PubMed ID: 21501147
[TBL] [Abstract][Full Text] [Related]
8. Involvement of CB1 and CB2 receptors in the modulation of cholinergic neurotransmission in mouse gastric preparations.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Sep; 56(3):185-92. PubMed ID: 17656103
[TBL] [Abstract][Full Text] [Related]
9. Mediation of amphetamine-induced long-term depression of synaptic transmission by CB1 cannabinoid receptors in the rat amygdala.
Huang YC; Wang SJ; Chiou LC; Gean PW
J Neurosci; 2003 Nov; 23(32):10311-20. PubMed ID: 14614090
[TBL] [Abstract][Full Text] [Related]
10. Adolescent chronic mild stress alters hippocampal CB1 receptor-mediated excitatory neurotransmission and plasticity.
Reich CG; Mihalik GR; Iskander AN; Seckler JC; Weiss MS
Neuroscience; 2013 Dec; 253():444-54. PubMed ID: 24035826
[TBL] [Abstract][Full Text] [Related]
11. Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses.
Kim J; Alger BE
Nat Neurosci; 2010 May; 13(5):592-600. PubMed ID: 20348918
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a modulatory role of cannabinoids on the excitatory NANC neurotransmission in mouse colon.
Mulè F; Amato A; Baldassano S; Serio R
Pharmacol Res; 2007 Aug; 56(2):132-9. PubMed ID: 17574859
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid signaling in inhibitory autaptic hippocampal neurons.
Straiker A; Mackie K
Neuroscience; 2009 Sep; 163(1):190-201. PubMed ID: 19501632
[TBL] [Abstract][Full Text] [Related]
14. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM
J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227
[TBL] [Abstract][Full Text] [Related]
15. Cannabinoid receptor agonists modulate calcium channels in rat retinal Müller cells.
Yang W; Li Q; Wang SY; Gao F; Qian WJ; Li F; Ji M; Sun XH; Miao Y; Wang Z
Neuroscience; 2016 Jan; 313():213-24. PubMed ID: 26621126
[TBL] [Abstract][Full Text] [Related]
16. Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus.
Di S; Boudaba C; Popescu IR; Weng FJ; Harris C; Marcheselli VL; Bazan NG; Tasker JG
J Physiol; 2005 Dec; 569(Pt 3):751-60. PubMed ID: 16239276
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cyclooxygenase-2 elicits a CB1-mediated decrease of excitatory transmission in rat CA1 hippocampus.
Slanina KA; Schweitzer P
Neuropharmacology; 2005 Oct; 49(5):653-9. PubMed ID: 15936781
[TBL] [Abstract][Full Text] [Related]
18. A novel non-CB1/TRPV1 endocannabinoid-mediated mechanism depresses excitatory synapses on hippocampal CA1 interneurons.
Edwards JG; Gibson HE; Jensen T; Nugent F; Walther C; Blickenstaff J; Kauer JA
Hippocampus; 2012 Feb; 22(2):209-21. PubMed ID: 21069781
[TBL] [Abstract][Full Text] [Related]
19. Anandamide potentiation of miniature spontaneous excitatory synaptic transmission is mediated via IP3 pathway.
Sang N; Zhang J; Chen C
Neurochem Int; 2010 Mar; 56(4):590-6. PubMed ID: 20064571
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of the sleep-inducing lipid oleamide and cannabinoids on the induction of long-term potentiation in the CA1 neurons of the rat hippocampus in vitro.
Lees G; Dougalis A
Brain Res; 2004 Jan; 997(1):1-14. PubMed ID: 14715144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
